DoD

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

The two-year contract will be used to develop a portable prototype to quickly identify critical infectious pathogens considered threatening to war combatants.

The consortium aims to identify tuberculosis protein targets and corresponding small molecule inhibitors that can be used to develop drugs to shorten therapy duration.

The study aims to explore the "unique benefits and challenges" or incorporating genomic information into the routine care of active duty Air Force members.

The study being conducted under the Genomes2People umbrella will explore how best to introduce genetic information into the routine care of active duty service members. 

Bioinformatics firm Berg is combining multi-omics data from the Department of Defense's Center for Prostate Disease Research in search of biomarkers.

The funding will go toward completing the development of the company's point-of-care platform for distinguishing bacterial from viral infections.

The funding will advance work focused on the discovery of a genomic configuration that correlates to chemotherapy sensitivity.

It was a rough year for biotech stocks — the Nasdaq Biotech Index fell 22 percent even as the Dow gained 13 percent and the Nasdaq gained 8 percent.

The company's Keystone platform will have an iPhone-esque application platform for different tools used for forensic DNA data analysis. 

Pages

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.